5 Top Uranium News Stories of 2018

2018 saw hope and attention return to the uranium market as supply fell and demand rose. Here are our top...

Uranium Outlook 2019: Supply to Fall, Demand to Rise — Prices to Jump?

2018 was an eventful year for uranium, but what's the uranium outlook for 2019? Experts weigh in on supply cuts,...

Opiant Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Opiant Pharmaceuticals (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug abuse, today announced the pricing of...

electroCore Announces Closing of Initial Public Offering

electroCore (Nasdaq:ECOR) today announced the closing of its initial public offering of 5,200,000 shares of common stock at a public...

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.

Big Pharma M&A: Shire Reviews Fourth Acquisition Proposal from Takeda

Takeda Pharmaceuticals may become a top global drugmaker with positions in treatments for cancers, gastrointestinal diseases and nervous-system disorders.

Shire Receives FDA Approval for Rare Disease Drug, Share Price Rises

Shire has received another FDA approval with the second approval for Vonvendi, a treatment for perioperative bleeding management in adults...